America Has a New GLP-1 Playbook
By most measures, the new GLP-1 pills are underwhelming. Earlier this month, the pharmaceutical giant Eli Lilly debuted a weight-loss tablet that is far less effective than its popular injectable counterpart, Zepbound. Oral Wegovy, which hit the market in December, can hold its own with the shot version—but it has to be taken on an […]